Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Class A Common Stock, $0.0001 par value per share
Symbol
RANI on Nasdaq
Shares outstanding
99,823,000
Price per share
$1.35
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
4,033,213
Total reported value
$2,015,817
% of total 13F portfolios
0%
Share change
-2,425,419
Value change
-$1,258,453
Number of holders
36
Price from insider filings
$1.35
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
InCube Labs, L.L.C. 22% $13,541,357 27,093,552 MIR A IMRAN 23 Oct 2025
Samsara BioCapital, L.P. 9.9% $4,939,262 9,882,477 Srinivas Akkaraju 23 Oct 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $4,939,262 9,882,477 RA Capital Management, L.P. 23 Oct 2025
Invus Global Management, LLC 10% $4,910,990 9,825,911 Raymond Debbane 16 Oct 2025
ARMISTICE CAPITAL, LLC 9.9% $4,131,600 6,260,000 Armistice Capital, LLC 30 Jun 2025
South Cone Investments Limited Partnership 4.9% $1,189,121 2,379,194 South Cone Investments Limited Partnership 20 Oct 2025
Orca Capital AG 4.3% -56% $972,105 -$1,265,416 1,891,623 -57% Orca Capital AG 22 Jul 2025

As of 30 Sep 2025, 36 institutional investors reported holding 4,033,213 shares of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI). This represents 4% of the company’s total 99,823,000 outstanding shares.

Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 218,076 $294,403 +$1,696 $1.35 3
2025 Q3 4,033,213 $2,015,817 -$1,258,453 $0.50 36
2025 Q2 6,458,632 $3,319,783 +$1,060,111 $0.51 38
2025 Q1 3,609,389 $4,577,211 -$332,797 $1.26 38
2024 Q4 3,819,967 $5,233,595 -$4,950,047 $1.37 42
2024 Q3 5,911,071 $12,767,865 +$5,999,502 $2.16 31
2024 Q2 3,108,475 $11,809,884 -$1,252,441 $3.80 33
2024 Q1 3,453,784 $10,741,251 +$509,498 $3.11 35
2023 Q4 3,290,303 $10,923,496 -$819,783 $3.32 33
2023 Q3 3,207,291 $6,961,738 -$151,646 $2.18 32
2023 Q2 3,227,286 $13,256,941 +$994,179 $4.12 34
2023 Q1 2,999,366 $15,475,095 +$204,634 $5.16 35
2022 Q4 2,885,407 $17,024,416 -$1,472,942 $5.90 32
2022 Q3 3,174,344 $30,405,447 +$3,581,808 $9.58 30
2022 Q2 2,824,819 $29,094,000 +$2,769,956 $10.33 27
2022 Q1 2,556,816 $34,515,000 +$17,568,047 $13.50 23
2021 Q4 1,240,919 $20,288,000 +$544,189 $16.35 21
2021 Q3 1,097,698 $19,562,000 +$19,562,000 $17.82 14